ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RUA Rua Life Sciences Plc

10.75
0.50 (4.88%)
Last Updated: 11:00:24
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rua Life Sciences Plc LSE:RUA London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 4.88% 10.75 10.50 11.00 10.75 10.25 10.25 344,898 11:00:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 2.18M -2M -0.0323 -3.33 6.67M
Rua Life Sciences Plc is listed in the Plastics,resins,elastomers sector of the London Stock Exchange with ticker RUA. The last closing price for Rua Life Sciences was 10.25p. Over the last year, Rua Life Sciences shares have traded in a share price range of 8.65p to 58.50p.

Rua Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of Rua Life Sciences is £6.67 million. Rua Life Sciences has a price to earnings ratio (PE ratio) of -3.33.

Rua Life Sciences Share Discussion Threads

Showing 1826 to 1850 of 3625 messages
Chat Pages: Latest  85  84  83  82  81  80  79  78  77  76  75  74  Older
DateSubjectAuthorDiscuss
29/12/2021
12:49
Looks like someone is dumping stock….either it is a distressed big holder or may even be an II colluding with a big player to facilitate cheap takeover! This is the most likely explanation. Uncertainty around FDA 510k is not the entire cause of this!
aykon
29/12/2021
12:45
They need to put out a release with total upfront honesty warts and all. The share price is more likely to recover/stabilise if they lay it all out so investors can stop speculating. Too much uncertainty and if they don't address it they'll be raising at a much lower price unfortunately. Get that release out and get it done
mikeh30
29/12/2021
12:08
PS looks like dogsh*te capital are still on our side after buying in at 130, so their unrealised loss is bigger than mine lol.
the_real_mr_big
29/12/2021
12:07
As long as I'm not looking at the sp, I'm getting more optimistic.

From a glimpse of the FDA 510k clinical studies presentation:

- 10-15% of 510k applications require clinical studies.
Looks like we're just 1-in-10 cases. Big de-stresser for me, as I thought our problems were more along the lines of inability to use 510k route.

- Size of clinical studies dictated by the ability of bench & animal testing to answer questions. Hopefully, we just need a few extra data points satisfied, but wtfdik.

Sitting on a huge loss here, but I can see this bouncing back up on a slither of good news. Until then I'll keep on holding on to this falling knife until I bleed dry. Bring on the FDA response in January.

£15m mcap with £4m in cash and increasing revenues seems like the time to top up. Be greedy when everyone's planting trees, or whatever it was that Buffy said.

the_real_mr_big
29/12/2021
12:00
Uncertainty and sentiment trumps everything else on illiquid AIM stocks unfortunately
mikeh30
29/12/2021
11:31
Come on. £15m mcap and it's falling. Seriously?
the_real_mr_big
23/12/2021
07:57
Buywell asks has Buywell ever spotted an overvalued share Before it has collapsed. Buywell needs to ask Buywell why is investing easy with benefit of hindsight.
amt
22/12/2021
12:05
The latest recruits came at the perfect time.

The CFO has been through this before. The reg and clinical affairs chap arrived 6 weeks too late, but at least we can benefit from his experience.

At current levels an opportunistic approach is an obvious risk. But if they get the new strategy right, with, say a £m strategic investment in new shares from an industry partner, all the angst will dissipate overnight. I did not buy the shares for the grafts or the patches. I bought for the massive heart-valve IP value and the Elasteon enabled disruption as the end of using animal derived material inevitably arrives.

greedy rooster
22/12/2021
10:09
Amati dumping.
This is bad.

the_real_mr_big
22/12/2021
07:24
POST REMOVED
buywell3
22/12/2021
06:40
POST REMOVED
buywell3
21/12/2021
08:34
Well what can one say that has already hasn't been said.The fact is unless the board buy shares why should we investors !
cocker
21/12/2021
01:08
POST REMOVED
buywell3
20/12/2021
21:36
POST REMOVED
buywell3
20/12/2021
16:42
We didn't need to evolve into a large company - the 510k would have provided new cash for more R&D and increased the value of the graft business to be sold off.

Anyway, nice to see some recovery. Has anyone managed a top up in the 60s? I only managed mid 70s.

the_real_mr_big
20/12/2021
13:16
I’m still in but not sure that there will be any more video presentations.
semper vigilans
20/12/2021
09:55
I still think that most investors don’t realise that this is essentially an R&D company (and with licensing rights to Elasteon). It is never going to evolve into a major graft company! The way the last update (last week£ has been structured does suggest to me that they have laid the stall to attract buyers for some part(s) of the company. However, this is my personal opinion of how I perceive it.
aykon
20/12/2021
09:21
That’s very baa.baa..baar..baric Mr Big!!!
aykon
20/12/2021
09:10
Yep. Packed onto a trailer, transported all the way up to Aberdeen and f.cked deep and hard.
the_real_mr_big
20/12/2021
09:04
Just can’t get away from sheep references on this thread!
bones
20/12/2021
09:00
Looks like a lot of PIs that panic sold have been well and truly fleeced!!
aykon
20/12/2021
08:54
Being optimistic. Won't happen any time soon.

The only problem with RUA now is the long delay before commercialising grafts. 18 months perhaps? That's too long for many PIs but nothing for IIs, so I'd expect a transfer of stock from PI to II hands.

Looks like the share price chart has got a morning stiffy. Long may it continue.

the_real_mr_big
20/12/2021
07:33
If directors aren't buying at these levels why should we!. Only excuse is in talks to sell something, or is that me being optimistic!
cocker
20/12/2021
02:35
POST REMOVED
buywell3
20/12/2021
00:10
Oh my, he's copypasting charts now.

Could it be that some II wants cheap shares and is paying this schmuck overtime for working on a Sunday?

the_real_mr_big
Chat Pages: Latest  85  84  83  82  81  80  79  78  77  76  75  74  Older

Your Recent History

Delayed Upgrade Clock